| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |